Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B (Daniel McCoy/Wichita Business Journal)
Boston-based Valo Health has raised $300 million in a new round of funding. The company will use the money …